NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|181344480|ref|NP_001116730|]
View 

aminopeptidase O [Danio rerio]

Protein Classification

M1 family metallopeptidase( domain architecture ID 10329665)

M1 family metallopeptidase is a zinc-dependent metallopeptidase that functions as an aminopeptidase and contains an HEXXH motif as part of its active site; such as aminopeptidase B that selectively removes arginine and/or lysine residues from the N-terminus of peptide substrates

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
GluZincin super family cl14813
Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, ...
213-617 5.38e-47

Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, M2, M3, M4, M13, M32 and M36 (fungalysins); The Gluzincin family (thermolysin-like peptidases or TLPs) includes several zinc-dependent metallopeptidases such as M1, M2, M3, M4, M13, M32, M36 peptidases (MEROPS classification), which contain the HEXXH motif as part of their active site. Peptidases in this family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile on activation during catalysis. The M1 family includes aminopeptidase N (APN) and leukotriene A4 hydrolase (LTA4H). APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity such that the two activities occupy different, but overlapping sites. The M3_like peptidases include the M2_ACE, M3 or neurolysin-like family (subfamilies M3B_PepF and M3A) and M32_Taq peptidases. The M2 peptidase angiotensin converting enzyme (ACE, EC 3.4.15.1) catalyzes the conversion of decapeptide angiotensin I to the potent vasopressor octapeptide angiotensin II. ACE is a key component of the renin-angiotensin system that regulates blood pressure, thus ACE inhibitors are important for the treatment of hypertension. M3A includes thimet oligopeptidase (TOP; endopeptidase 3.4.24.15), neurolysin (3.4.24.16), and the mitochondrial intermediate peptidase; and M3B includes oligopeptidase F. The M32 family includes eukaryotic enzymes from protozoa Trypanosoma cruzi, a causative agent of Chagas' disease, and from Leishmania major, a parasite that causes leishmaniasis, making these enzymes attractive targets for drug development. The M4 family includes secreted protease thermolysin (EC 3.4.24.27), pseudolysin, aureolysin, and neutral protease as well as bacillolysin (EC 3.4.24.28) that degrade extracellular proteins and peptides for bacterial nutrition, especially prior to sporulation. Thermolysin is widely used as a nonspecific protease to obtain fragments for peptide sequencing as well as in production of the artificial sweetener aspartame. The M13 family includes neprilysin (EC 3.4.24.11) and endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), which fulfill a broad range of physiological roles due to the greater variation in the S2' subsite allowing substrate specificity and are prime therapeutic targets for selective inhibition. The peptidase M36 fungalysin family includes endopeptidases from pathogenic fungi. Fungalysin hydrolyzes extracellular matrix proteins such as elastin and keratin. Aspergillus fumigatus causes the pulmonary disease aspergillosis by invading the lungs of immuno-compromised animals and secreting fungalysin that possibly breaks down proteinaceous structural barriers.


The actual alignment was detected with superfamily member cd09599:

Pssm-ID: 472708 [Multi-domain]  Cd Length: 442  Bit Score: 173.41  E-value: 5.38e-47
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 213 VRIWYETKPTGGSVRW-TKDQ-DGRCC--VYTMGSPINNRALFPCQEPPVAMSTWQACVRAPCDFTVLMSGENQAFPEPA 288
Cdd:cd09599   98 VKIEYSTTPQATALQWlTPEQtAGKKHpyLFTQCQAIHARSLFPCQDTPSVKSTYSATVTVPKGLTALMSALRTGEKEEA 177
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 289 ETG---FQQwdyyvTMPMPASTFTIAVGQwleaevkvtnyvddklslpLDSGDeeyicshmdypcrfmVGPaRVqtviph 365
Cdd:cd09599  178 GTGtytFEQ-----PVPIPSYLIAIAVGD-------------------LESRE---------------IGP-RS------ 211
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 366 RVFAPSCHLQKAQ----DMvlpllPLCLTAAHSVLGVHPFPRLDVLIVPSGFSSLGMASPHIVFLSQSVLTGERNLCGAr 441
Cdd:cd09599  212 GVWAEPSVVDAAAeefaDT-----EKFLKAAEKLYGPYVWGRYDLLVLPPSFPYGGMENPCLTFATPTLIAGDRSLVDV- 285
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 442 LCHEIAHSWFGLAIGARDWTEEWISEGFATYLEdvfwshvQK-LGCREAEEQRQLKALLRWRRLSDELQNSEE--ELQVL 518
Cdd:cd09599  286 IAHEIAHSWSGNLVTNANWEHFWLNEGFTVYLE-------RRiLERLYGEEYRQFEAILGWKDLQESIKEFGEdpPYTLL 358
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 519 RPNKENTgevsesgasvvkhalNPEKPFMQVHYLKGYFLLKFLADQIGEEKFLQFFKVFVGKFHGQLILSQDFLQMLLDA 598
Cdd:cd09599  359 VPDLKGV---------------DPDDAFSSVPYEKGFQFLYYLEQLGGREVFDPFLRAYFKKFAFQSIDTEDFKDFLLEY 423
                        410       420
                 ....*....|....*....|
gi 181344480 599 FPAmsSQGIALETI-FSDWL 617
Cdd:cd09599  424 FAE--DKPEILDKIdWDAWL 441
Leuk-A4-hydro_C pfam09127
Leukotriene A4 hydrolase, C-terminal; Members of this family adopt a structure consisting of ...
693-786 7.61e-18

Leukotriene A4 hydrolase, C-terminal; Members of this family adopt a structure consisting of two layers of parallel alpha-helices, five in the inner layer and four in the outer, arranged in an antiparallel manner, with perpendicular loops containing short helical segments on top. They are required for the formation of a deep cleft harbouring the catalytic Zn2+ site in Leukotriene A4 hydrolase.


:

Pssm-ID: 462686  Cd Length: 112  Bit Score: 79.84  E-value: 7.61e-18
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480  693 SASTLRLLQSTYNL-QAQDAEVKHRWCELAVKHKHTAAYRDVELFLIH--DQAMGVYLYGELMVQEdarqQALARRCLSI 769
Cdd:pfam09127  20 SPEQLKALDEVYKLsESKNAEIRFRWLRLALKAKYEPAYPEVAEFLGEvgRMKFVRPLYRALNKVD----RDLAVETFEK 95
                          90
                  ....*....|....*..
gi 181344480  770 IKDDMDQSARTVVEEMI 786
Cdd:pfam09127  96 NKDFYHPICRAMVEKDL 112
 
Name Accession Description Interval E-value
M1_LTA4H cd09599
Peptidase M1 family including Leukotriene A4 hydrolase catalytic domain; This model represents ...
213-617 5.38e-47

Peptidase M1 family including Leukotriene A4 hydrolase catalytic domain; This model represents the N-terminal catalytic domain of leukotriene A4 hydrolase (LTA4H; E.C. 3.3.2.6) and the close homolog cold-active aminopeptidase (Colwellia psychrerythraea-type peptidase; ColAP), both members of the aminopeptidase M1 family. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity. The two activities occupy different, but overlapping sites. The activity and physiological relevance of the aminopeptidase is poorly understood while the epoxide hydrolase converts leukotriene A4 (LTA4) into leukotriene B4 (LTB4), a potent chemotaxin that is fundamental to the inflammatory response of mammals. It accepts a variety of substrates, including some opioid, di- and tripeptides, as well as chromogenic aminoacyl-p-nitroanilide derivatives. The aminopeptidase activity of LTA4H is possibly involved in the processing of peptides related to inflammation and host defense. Kinetic analysis shows that LTA4H hydrolyzes arginyl tripeptides with high efficiency and specificity, indicating its function as an arginyl aminopeptidase. Thermodynamic characterization using different biophysical methods shows that structurally distinct inhibitors of the LTA4H occupy different regions of the binding site; while some (RB202, ARM1 and SC57461A) bind to the hydrophobic hydrolase side, both bestatin and captopril are located at the hydrophilic peptidase side. LTB4H overexpression is associated with different pathological conditions and diseases such as cystic fibrosis, coronary heart disease, sepsis, shock, connective tissue disease, and chronic obstructive pulmonary disease. It is also overexpressed in certain human cancers, and has been identified as a functionally important target for mediating anticancer properties of resveratrol, a well-known red wine polyphenolic compound with cancer chemopreventive activity.


Pssm-ID: 341062 [Multi-domain]  Cd Length: 442  Bit Score: 173.41  E-value: 5.38e-47
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 213 VRIWYETKPTGGSVRW-TKDQ-DGRCC--VYTMGSPINNRALFPCQEPPVAMSTWQACVRAPCDFTVLMSGENQAFPEPA 288
Cdd:cd09599   98 VKIEYSTTPQATALQWlTPEQtAGKKHpyLFTQCQAIHARSLFPCQDTPSVKSTYSATVTVPKGLTALMSALRTGEKEEA 177
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 289 ETG---FQQwdyyvTMPMPASTFTIAVGQwleaevkvtnyvddklslpLDSGDeeyicshmdypcrfmVGPaRVqtviph 365
Cdd:cd09599  178 GTGtytFEQ-----PVPIPSYLIAIAVGD-------------------LESRE---------------IGP-RS------ 211
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 366 RVFAPSCHLQKAQ----DMvlpllPLCLTAAHSVLGVHPFPRLDVLIVPSGFSSLGMASPHIVFLSQSVLTGERNLCGAr 441
Cdd:cd09599  212 GVWAEPSVVDAAAeefaDT-----EKFLKAAEKLYGPYVWGRYDLLVLPPSFPYGGMENPCLTFATPTLIAGDRSLVDV- 285
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 442 LCHEIAHSWFGLAIGARDWTEEWISEGFATYLEdvfwshvQK-LGCREAEEQRQLKALLRWRRLSDELQNSEE--ELQVL 518
Cdd:cd09599  286 IAHEIAHSWSGNLVTNANWEHFWLNEGFTVYLE-------RRiLERLYGEEYRQFEAILGWKDLQESIKEFGEdpPYTLL 358
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 519 RPNKENTgevsesgasvvkhalNPEKPFMQVHYLKGYFLLKFLADQIGEEKFLQFFKVFVGKFHGQLILSQDFLQMLLDA 598
Cdd:cd09599  359 VPDLKGV---------------DPDDAFSSVPYEKGFQFLYYLEQLGGREVFDPFLRAYFKKFAFQSIDTEDFKDFLLEY 423
                        410       420
                 ....*....|....*....|
gi 181344480 599 FPAmsSQGIALETI-FSDWL 617
Cdd:cd09599  424 FAE--DKPEILDKIdWDAWL 441
PepN COG0308
Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];
182-624 2.19e-39

Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];


Pssm-ID: 440077 [Multi-domain]  Cd Length: 609  Bit Score: 154.80  E-value: 2.19e-39
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 182 VNTQPLQFHMDRWSLQIRKKGVRTPHDfPCAVRIWYETKPTGGSV---RWTKDQDGRCCVYTMGSPINNRALFPCQEPPV 258
Cdd:COG0308   65 VDGKPLDFTRDGERLTITLPKPLAPGE-TFTLEIEYSGKPSNGGEglyRSGDPPDGPPYLYTQCEPEGARRWFPCFDHPD 143
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 259 AMSTWQACVRAPCDFTVLMSGENQAfPEPAETGFQQWDYYVTMPMPASTFTIAVGQWleaevkvtnyvdDKLSLPLDSGd 338
Cdd:COG0308  144 DKATFTLTVTVPAGWVAVSNGNLVS-ETELGDGRTTWHWADTQPIPTYLFALAAGDY------------AVVEDTFASG- 209
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 339 eeyicshmdypcrfmvgparvqtvIPHRVFAPSCHLQKAQDMvLPLLPLCLTAAHSVLGV-HPFPRLDVLIVPSgFSSLG 417
Cdd:COG0308  210 ------------------------VPLRVYVRPGLADKAKEA-FESTKRMLDFFEELFGVpYPFDKYDQVAVPD-FNFGA 263
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 418 MASPHIVFLSQSVLTGERNLCGAR------LCHEIAHSWFGLAIGARDWTEEWISEGFATYLEDVFWSHVQKlgcREAEE 491
Cdd:COG0308  264 MENQGLVTFGEKVLADETATDADYerresvIAHELAHQWFGNLVTCADWDDLWLNEGFATYMEQLFSEDLYG---KDAAD 340
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 492 QRQLKALLRWRRLSDELQNSeeelQVLRPNKENtgevsesgasvvkhalNPEKPFMQVHYLKGYFLLKFLADQIGEEKFL 571
Cdd:COG0308  341 RIFVGALRSYAFAEDAGPNA----HPIRPDDYP----------------EIENFFDGIVYEKGALVLHMLRTLLGDEAFR 400
                        410       420       430       440       450
                 ....*....|....*....|....*....|....*....|....*....|....
gi 181344480 572 QFFKVFVGKFHGQLILSQDFLQmlldafpAMSSQ-GIALETIFSDWLDTPEMPE 624
Cdd:COG0308  401 AGLRLYFARHAGGNATTEDFLA-------ALEEAsGRDLSAFFDQWLYQAGLPT 447
leuko_A4_hydro TIGR02411
leukotriene A-4 hydrolase/aminopeptidase; Members of this family represent a distinctive ...
211-737 2.25e-35

leukotriene A-4 hydrolase/aminopeptidase; Members of this family represent a distinctive subset within the zinc metallopeptidase family M1 (pfam01433). The majority of the members of pfam01433 are aminopeptidases, but the sequences in this family for which the function is known are leukotriene A-4 hydrolase. A dual epoxide hydrolase and aminopeptidase activity at the same active site is indicated. The physiological substrate for aminopeptidase activity is not known.


Pssm-ID: 274120 [Multi-domain]  Cd Length: 602  Bit Score: 142.61  E-value: 2.25e-35
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480  211 CAVRIWYETKPTGGSVRW-TKDQ-DGRCCVYTMGS--PINNRALFPCQEPPVAMSTWQACVRAPcdFTVLMSG--ENQAF 284
Cdd:TIGR02411  95 FVLNISFSTTPKCTALQWlNPEQtSGKKHPYLFSQcqAIHARSLFPCQDTPSVKSTYTAEVESP--LPVLMSGirDGETS 172
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480  285 PEPAETGFQQwdyyvTMPMPASTFTIAVGqwleaevkvtnyvdDKLSLPLdsgdeeyicshmdypcrfmvGPArvQTVIP 364
Cdd:TIGR02411 173 NDPGKYLFKQ-----KVPIPAYLIAIASG--------------DLASAPI--------------------GPR--STVYS 211
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480  365 HRVFAPSCHLQKAQDMvlpllPLCLTAAHSVLGVHPFPRLDVLIVPSGFSSLGMASPHIVFLSQSVLTGERNLCGArLCH 444
Cdd:TIGR02411 212 EPEQLEKCQYEFENDT-----EKFIKTAEDLIFPYEWGQYDLLVLPPSFPYGGMENPNLTFATPTLIAGDRSNVDV-IAH 285
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480  445 EIAHSWFGLAIGARDWTEEWISEGFATYLEdvfwSHVqkLGCREAEEQRQLKALLRWrrlsDELQNSEEELqvlrpnken 524
Cdd:TIGR02411 286 ELAHSWSGNLVTNCSWEHFWLNEGWTVYLE----RRI--IGRLYGEKTRHFSALIGW----GDLQESVKTL--------- 346
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480  525 tGEVSESGASVVKhaLNPEKP---FMQVHYLKGYFLLKFLADQIG-EEKFLQFFKVFVGKFHGQLILSQDFLQMLLDAFP 600
Cdd:TIGR02411 347 -GETPEFTKLVVD--LKDNDPddaFSSVPYEKGFNFLFYLEQLLGgPAEFDPFLRHYFKKFAYKSLDTYQFKDALYEYFK 423
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480  601 AMSSQGIALETIFSDWLDTPEMP-------EWLRDEC----SEWLrtpavqevkgEVAKWIHFSGSGGKGSKRKRAGPKV 669
Cdd:TIGR02411 424 DKKKVDKLDAVDWETWLYSPGMPpvkpnfdTTLADECyalaDRWV----------DAAKADDLSSFNAKDIKDFSSHQLV 493
                         490       500       510       520       530       540
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 181344480  670 NFKElnpeqlvlLLEFLLEECNLSASTLRLLQSTYNLQA-QDAEVKHRWCELAVKHKHTAAYRDVELFL 737
Cdd:TIGR02411 494 LFLE--------TLTERGGDWALPEGHIKRLGDIYNFAAsKNAEVRFRWFRLAIQAKLEDEYPLLADWL 554
Leuk-A4-hydro_C pfam09127
Leukotriene A4 hydrolase, C-terminal; Members of this family adopt a structure consisting of ...
693-786 7.61e-18

Leukotriene A4 hydrolase, C-terminal; Members of this family adopt a structure consisting of two layers of parallel alpha-helices, five in the inner layer and four in the outer, arranged in an antiparallel manner, with perpendicular loops containing short helical segments on top. They are required for the formation of a deep cleft harbouring the catalytic Zn2+ site in Leukotriene A4 hydrolase.


Pssm-ID: 462686  Cd Length: 112  Bit Score: 79.84  E-value: 7.61e-18
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480  693 SASTLRLLQSTYNL-QAQDAEVKHRWCELAVKHKHTAAYRDVELFLIH--DQAMGVYLYGELMVQEdarqQALARRCLSI 769
Cdd:pfam09127  20 SPEQLKALDEVYKLsESKNAEIRFRWLRLALKAKYEPAYPEVAEFLGEvgRMKFVRPLYRALNKVD----RDLAVETFEK 95
                          90
                  ....*....|....*..
gi 181344480  770 IKDDMDQSARTVVEEMI 786
Cdd:pfam09127  96 NKDFYHPICRAMVEKDL 112
Peptidase_M1 pfam01433
Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ ...
400-616 8.93e-17

Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ widely in specificity, hydrolysing acidic, basic or neutral N-terminal residues. This family includes leukotriene-A4 hydrolase, this enzyme also has an aminopeptidase activity.


Pssm-ID: 426262 [Multi-domain]  Cd Length: 219  Bit Score: 80.03  E-value: 8.93e-17
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480  400 PFPRLDVLIVPSgFSSLGMASPHIVFLSQSVLTGERNLCGAR--------LCHEIAHSWFGLAIGARDWTEEWISEGFAT 471
Cdd:pfam01433  22 PLPKYDLVALPD-FSAGAMENWGLITYRETLLLYDPGNSSTSdkqrvasvIAHELAHQWFGNLVTMKWWDDLWLNEGFAT 100
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480  472 YLEDVFWSHVQklGCREAEEQRQLKALlrWRRLSDELQNSEEELQVlrpnkeNTGEVSEsgasvvkhalnPEKPFMQVHY 551
Cdd:pfam01433 101 YMEYLGTDALF--PEWNIWEQFLLDEV--QNAMARDALDSSHPITQ------NVNDPSE-----------IDDIFDAIPY 159
                         170       180       190       200       210       220
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 181344480  552 LKGYFLLKFLADQIGEEKFLQFFKVFVGKFHGQLILSQDFLQMLLDAfpamsSQGIALETIFSDW 616
Cdd:pfam01433 160 EKGASVLRMLETLLGEEVFQKGLRSYLKKFQYGNATTEDLWDALSEA-----SGPLDVDSFMDTW 219
 
Name Accession Description Interval E-value
M1_LTA4H cd09599
Peptidase M1 family including Leukotriene A4 hydrolase catalytic domain; This model represents ...
213-617 5.38e-47

Peptidase M1 family including Leukotriene A4 hydrolase catalytic domain; This model represents the N-terminal catalytic domain of leukotriene A4 hydrolase (LTA4H; E.C. 3.3.2.6) and the close homolog cold-active aminopeptidase (Colwellia psychrerythraea-type peptidase; ColAP), both members of the aminopeptidase M1 family. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity. The two activities occupy different, but overlapping sites. The activity and physiological relevance of the aminopeptidase is poorly understood while the epoxide hydrolase converts leukotriene A4 (LTA4) into leukotriene B4 (LTB4), a potent chemotaxin that is fundamental to the inflammatory response of mammals. It accepts a variety of substrates, including some opioid, di- and tripeptides, as well as chromogenic aminoacyl-p-nitroanilide derivatives. The aminopeptidase activity of LTA4H is possibly involved in the processing of peptides related to inflammation and host defense. Kinetic analysis shows that LTA4H hydrolyzes arginyl tripeptides with high efficiency and specificity, indicating its function as an arginyl aminopeptidase. Thermodynamic characterization using different biophysical methods shows that structurally distinct inhibitors of the LTA4H occupy different regions of the binding site; while some (RB202, ARM1 and SC57461A) bind to the hydrophobic hydrolase side, both bestatin and captopril are located at the hydrophilic peptidase side. LTB4H overexpression is associated with different pathological conditions and diseases such as cystic fibrosis, coronary heart disease, sepsis, shock, connective tissue disease, and chronic obstructive pulmonary disease. It is also overexpressed in certain human cancers, and has been identified as a functionally important target for mediating anticancer properties of resveratrol, a well-known red wine polyphenolic compound with cancer chemopreventive activity.


Pssm-ID: 341062 [Multi-domain]  Cd Length: 442  Bit Score: 173.41  E-value: 5.38e-47
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 213 VRIWYETKPTGGSVRW-TKDQ-DGRCC--VYTMGSPINNRALFPCQEPPVAMSTWQACVRAPCDFTVLMSGENQAFPEPA 288
Cdd:cd09599   98 VKIEYSTTPQATALQWlTPEQtAGKKHpyLFTQCQAIHARSLFPCQDTPSVKSTYSATVTVPKGLTALMSALRTGEKEEA 177
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 289 ETG---FQQwdyyvTMPMPASTFTIAVGQwleaevkvtnyvddklslpLDSGDeeyicshmdypcrfmVGPaRVqtviph 365
Cdd:cd09599  178 GTGtytFEQ-----PVPIPSYLIAIAVGD-------------------LESRE---------------IGP-RS------ 211
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 366 RVFAPSCHLQKAQ----DMvlpllPLCLTAAHSVLGVHPFPRLDVLIVPSGFSSLGMASPHIVFLSQSVLTGERNLCGAr 441
Cdd:cd09599  212 GVWAEPSVVDAAAeefaDT-----EKFLKAAEKLYGPYVWGRYDLLVLPPSFPYGGMENPCLTFATPTLIAGDRSLVDV- 285
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 442 LCHEIAHSWFGLAIGARDWTEEWISEGFATYLEdvfwshvQK-LGCREAEEQRQLKALLRWRRLSDELQNSEE--ELQVL 518
Cdd:cd09599  286 IAHEIAHSWSGNLVTNANWEHFWLNEGFTVYLE-------RRiLERLYGEEYRQFEAILGWKDLQESIKEFGEdpPYTLL 358
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 519 RPNKENTgevsesgasvvkhalNPEKPFMQVHYLKGYFLLKFLADQIGEEKFLQFFKVFVGKFHGQLILSQDFLQMLLDA 598
Cdd:cd09599  359 VPDLKGV---------------DPDDAFSSVPYEKGFQFLYYLEQLGGREVFDPFLRAYFKKFAFQSIDTEDFKDFLLEY 423
                        410       420
                 ....*....|....*....|
gi 181344480 599 FPAmsSQGIALETI-FSDWL 617
Cdd:cd09599  424 FAE--DKPEILDKIdWDAWL 441
PepN COG0308
Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];
182-624 2.19e-39

Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];


Pssm-ID: 440077 [Multi-domain]  Cd Length: 609  Bit Score: 154.80  E-value: 2.19e-39
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 182 VNTQPLQFHMDRWSLQIRKKGVRTPHDfPCAVRIWYETKPTGGSV---RWTKDQDGRCCVYTMGSPINNRALFPCQEPPV 258
Cdd:COG0308   65 VDGKPLDFTRDGERLTITLPKPLAPGE-TFTLEIEYSGKPSNGGEglyRSGDPPDGPPYLYTQCEPEGARRWFPCFDHPD 143
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 259 AMSTWQACVRAPCDFTVLMSGENQAfPEPAETGFQQWDYYVTMPMPASTFTIAVGQWleaevkvtnyvdDKLSLPLDSGd 338
Cdd:COG0308  144 DKATFTLTVTVPAGWVAVSNGNLVS-ETELGDGRTTWHWADTQPIPTYLFALAAGDY------------AVVEDTFASG- 209
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 339 eeyicshmdypcrfmvgparvqtvIPHRVFAPSCHLQKAQDMvLPLLPLCLTAAHSVLGV-HPFPRLDVLIVPSgFSSLG 417
Cdd:COG0308  210 ------------------------VPLRVYVRPGLADKAKEA-FESTKRMLDFFEELFGVpYPFDKYDQVAVPD-FNFGA 263
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 418 MASPHIVFLSQSVLTGERNLCGAR------LCHEIAHSWFGLAIGARDWTEEWISEGFATYLEDVFWSHVQKlgcREAEE 491
Cdd:COG0308  264 MENQGLVTFGEKVLADETATDADYerresvIAHELAHQWFGNLVTCADWDDLWLNEGFATYMEQLFSEDLYG---KDAAD 340
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 492 QRQLKALLRWRRLSDELQNSeeelQVLRPNKENtgevsesgasvvkhalNPEKPFMQVHYLKGYFLLKFLADQIGEEKFL 571
Cdd:COG0308  341 RIFVGALRSYAFAEDAGPNA----HPIRPDDYP----------------EIENFFDGIVYEKGALVLHMLRTLLGDEAFR 400
                        410       420       430       440       450
                 ....*....|....*....|....*....|....*....|....*....|....
gi 181344480 572 QFFKVFVGKFHGQLILSQDFLQmlldafpAMSSQ-GIALETIFSDWLDTPEMPE 624
Cdd:COG0308  401 AGLRLYFARHAGGNATTEDFLA-------ALEEAsGRDLSAFFDQWLYQAGLPT 447
leuko_A4_hydro TIGR02411
leukotriene A-4 hydrolase/aminopeptidase; Members of this family represent a distinctive ...
211-737 2.25e-35

leukotriene A-4 hydrolase/aminopeptidase; Members of this family represent a distinctive subset within the zinc metallopeptidase family M1 (pfam01433). The majority of the members of pfam01433 are aminopeptidases, but the sequences in this family for which the function is known are leukotriene A-4 hydrolase. A dual epoxide hydrolase and aminopeptidase activity at the same active site is indicated. The physiological substrate for aminopeptidase activity is not known.


Pssm-ID: 274120 [Multi-domain]  Cd Length: 602  Bit Score: 142.61  E-value: 2.25e-35
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480  211 CAVRIWYETKPTGGSVRW-TKDQ-DGRCCVYTMGS--PINNRALFPCQEPPVAMSTWQACVRAPcdFTVLMSG--ENQAF 284
Cdd:TIGR02411  95 FVLNISFSTTPKCTALQWlNPEQtSGKKHPYLFSQcqAIHARSLFPCQDTPSVKSTYTAEVESP--LPVLMSGirDGETS 172
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480  285 PEPAETGFQQwdyyvTMPMPASTFTIAVGqwleaevkvtnyvdDKLSLPLdsgdeeyicshmdypcrfmvGPArvQTVIP 364
Cdd:TIGR02411 173 NDPGKYLFKQ-----KVPIPAYLIAIASG--------------DLASAPI--------------------GPR--STVYS 211
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480  365 HRVFAPSCHLQKAQDMvlpllPLCLTAAHSVLGVHPFPRLDVLIVPSGFSSLGMASPHIVFLSQSVLTGERNLCGArLCH 444
Cdd:TIGR02411 212 EPEQLEKCQYEFENDT-----EKFIKTAEDLIFPYEWGQYDLLVLPPSFPYGGMENPNLTFATPTLIAGDRSNVDV-IAH 285
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480  445 EIAHSWFGLAIGARDWTEEWISEGFATYLEdvfwSHVqkLGCREAEEQRQLKALLRWrrlsDELQNSEEELqvlrpnken 524
Cdd:TIGR02411 286 ELAHSWSGNLVTNCSWEHFWLNEGWTVYLE----RRI--IGRLYGEKTRHFSALIGW----GDLQESVKTL--------- 346
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480  525 tGEVSESGASVVKhaLNPEKP---FMQVHYLKGYFLLKFLADQIG-EEKFLQFFKVFVGKFHGQLILSQDFLQMLLDAFP 600
Cdd:TIGR02411 347 -GETPEFTKLVVD--LKDNDPddaFSSVPYEKGFNFLFYLEQLLGgPAEFDPFLRHYFKKFAYKSLDTYQFKDALYEYFK 423
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480  601 AMSSQGIALETIFSDWLDTPEMP-------EWLRDEC----SEWLrtpavqevkgEVAKWIHFSGSGGKGSKRKRAGPKV 669
Cdd:TIGR02411 424 DKKKVDKLDAVDWETWLYSPGMPpvkpnfdTTLADECyalaDRWV----------DAAKADDLSSFNAKDIKDFSSHQLV 493
                         490       500       510       520       530       540
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 181344480  670 NFKElnpeqlvlLLEFLLEECNLSASTLRLLQSTYNLQA-QDAEVKHRWCELAVKHKHTAAYRDVELFL 737
Cdd:TIGR02411 494 LFLE--------TLTERGGDWALPEGHIKRLGDIYNFAAsKNAEVRFRWFRLAIQAKLEDEYPLLADWL 554
M1 cd09595
Peptidase M1 family includes the catalytic domains of aminopeptidase N and leukotriene A4 ...
212-592 2.31e-26

Peptidase M1 family includes the catalytic domains of aminopeptidase N and leukotriene A4 hydrolase; The model represents the catalytic domains of M1 peptidase family members including aminopeptidase N (APN) and leukotriene A4 hydrolase (LTA4H). All peptidases in this family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile upon activation during catalysis. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types. APN expression is dysregulated in many inflammatory diseases and is enhanced in numerous tumor cells, making it a lead target in the development of anti-cancer and anti-inflammatory drugs. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity. The two activities occupy different, but overlapping sites. The activity and physiological relevance of the aminopeptidase in LTA4H is as yet unknown, while the epoxide hydrolase converts leukotriene A4 (LTA4) into leukotriene B4 (LTB4), a potent chemotaxin that is fundamental to the inflammatory response of mammals.


Pssm-ID: 341058 [Multi-domain]  Cd Length: 413  Bit Score: 112.54  E-value: 2.31e-26
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 212 AVRIWYETKPT------GGSVRWTKDQDGRccvYTMGSPINNRALFPCQEPPVAMSTWQACVRAPCDFTVLMSG-ENQAF 284
Cdd:cd09595   78 TVRISFEAKPSknllgwLWEQTAGKEKPYL---FTQFEATHARRIFPCIDHPAVKATFTVTITTPKKDLLASNGaLVGEE 154
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 285 PEPAETGFQQWDyyVTMPMPASTFTIAVGQWLEAEVKVTNYVDDKLSLpldsGDEEYICSHMDYPcrfmVGPARVQtvip 364
Cdd:cd09595  155 TGANGRKTYRFE--DTPPIPTYLVAVVVGDLEFKYVTVKSQPRVGLSV----YSEPLQVDQAQYA----FDATRAA---- 220
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 365 hrvfapschLQKAQD-MVLPllplcltaahsvlgvHPFPRLDVLIVPSgFSSLGMASPH-IVFLSQSVLTGERNLCGAR- 441
Cdd:cd09595  221 ---------LAWFEDyFGGP---------------YPLPKYDLLAVPD-FNSGAMENPGlITFRTTYLLRSKVTDTGARs 275
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 442 ----LCHEIAHSWFGLAIGARDWTEEWISEGFATYLEDVFwshvqkLGCREAEEQRQLKALLRWRRLSDelqnseeelqv 517
Cdd:cd09595  276 ienvIAHELAHQWFGNLVTMRWWNDLWLNEGFAVYYENRI------MDATFGTSSRHLDQLSGSSDLNT----------- 338
                        330       340       350       360       370       380       390
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 181344480 518 lrpnkentgEVSESGASVVKHAL----NPEKPFMQVHYLKGYFLLKFLADQIGEEKFLQFFKVFVGKFHGQLILSQDFL 592
Cdd:cd09595  339 ---------EQLLEDSSPTSTPVrspaDPDVAYDGVTYAKGALVLRMLEELVGEEAFDKGVQAYFNRHKFKNATTDDFI 408
M1_APN_like cd09603
Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains mostly ...
213-617 7.67e-19

Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains mostly bacterial and some archaeal M1 peptidases with smilarity to the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341066 [Multi-domain]  Cd Length: 410  Bit Score: 89.57  E-value: 7.67e-19
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 213 VRIWYETKPTGGSVRW---TKDQDGRCCVYTMGSPINNRALFPCQEPPVAMSTWQACVRAPCDFTVLMSGE--NQafpEP 287
Cdd:cd09603   81 VTVRYSGKPRPAGYPPgdgGGWEEGDDGVWTAGQPEGASTWFPCNDHPDDKATYDITVTVPAGLTVVSNGRlvST---TT 157
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 288 AETGFQQWDYYVTMPMPASTFTIAVGQWLEAE------VKVTNYVDDKLSlpldsgdeeyicshmdypcrfmvgpARVQT 361
Cdd:cd09603  158 NGGGTTTWHWKMDYPIATYLVTLAVGRYAVVEdgsgggIPLRYYVPPGDA-------------------------AKAKA 212
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 362 viphrvfapscHLQKAQDMvlpllplcLTAAHSVLGVHPFPRLDVLIVPSGFssLGMASPHIVFLSQSVLTGERNlcGAR 441
Cdd:cd09603  213 -----------SFARTPEM--------LDFFEELFGPYPFEKYGQVVVPDLG--GGMEHQTATTYGNNFLNGDRG--SER 269
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 442 L-CHEIAHSWFGLAIGARDWTEEWISEGFATYLEDVFWSHvqKLGcrEAEEQRQLKALLRWRRLSDELQNSEeelqvLRP 520
Cdd:cd09603  270 LiAHELAHQWFGDSVTCADWADIWLNEGFATYAEWLWSEH--KGG--ADAYRAYLAGQRQDYLNADPGPGRP-----PDP 340
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 521 NKENTGEVSESGASVVkHALNpekpfmqvhylkgyfllkflaDQIGEEKFLQFFKVFVGKFHGQLILSQDFLQmlldafp 600
Cdd:cd09603  341 DDLFDRDVYQKGALVL-HMLR---------------------NLLGDEAFFAALRAYLARYAHGNVTTEDFIA------- 391
                        410
                 ....*....|....*...
gi 181344480 601 AMSSQ-GIALETIFSDWL 617
Cdd:cd09603  392 AAEEVsGRDLTWFFDQWL 409
Leuk-A4-hydro_C pfam09127
Leukotriene A4 hydrolase, C-terminal; Members of this family adopt a structure consisting of ...
693-786 7.61e-18

Leukotriene A4 hydrolase, C-terminal; Members of this family adopt a structure consisting of two layers of parallel alpha-helices, five in the inner layer and four in the outer, arranged in an antiparallel manner, with perpendicular loops containing short helical segments on top. They are required for the formation of a deep cleft harbouring the catalytic Zn2+ site in Leukotriene A4 hydrolase.


Pssm-ID: 462686  Cd Length: 112  Bit Score: 79.84  E-value: 7.61e-18
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480  693 SASTLRLLQSTYNL-QAQDAEVKHRWCELAVKHKHTAAYRDVELFLIH--DQAMGVYLYGELMVQEdarqQALARRCLSI 769
Cdd:pfam09127  20 SPEQLKALDEVYKLsESKNAEIRFRWLRLALKAKYEPAYPEVAEFLGEvgRMKFVRPLYRALNKVD----RDLAVETFEK 95
                          90
                  ....*....|....*..
gi 181344480  770 IKDDMDQSARTVVEEMI 786
Cdd:pfam09127  96 NKDFYHPICRAMVEKDL 112
M1_APN_like cd09604
Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains ...
390-617 4.01e-17

Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains bacterial M1 peptidases with smilarity to the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341067 [Multi-domain]  Cd Length: 440  Bit Score: 84.63  E-value: 4.01e-17
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 390 TAAHSV------LGVHPFPRLDvlIVPSGFSSLGMASPHIVFLSQSVLTGERNLCGArLCHEIAHSWFGLAIG--ARDWT 461
Cdd:cd09604  242 YAKDALeffsekFGPYPYPELD--VVQGPFGGGGMEYPGLVFIGSRLYDPKRSLEGV-VVHEIAHQWFYGIVGndERREP 318
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 462 eeWISEGFATYLEDVFWSHVQKlgcreaeeqrQLKALLRWRRLSDELQNSEEELQVLRPNKENTGEVSESGASvvkhaln 541
Cdd:cd09604  319 --WLDEGLATYAESLYLEEKYG----------KEAADELLGRRYYRAYARGPGGPINLPLDTFPDGSYYSNAV------- 379
                        170       180       190       200       210       220       230
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 181344480 542 pekpfmqvhYLKGYFLLKFLADQIGEEKFLQFFKVFVGKFHGQLILSQDFLQMLLDAFpamssqGIALETIFSDWL 617
Cdd:cd09604  380 ---------YSKGALFLEELREELGDEAFDKALREYYRRYKFKHPTPEDFFRTAEEVS------GKDLDWFFRGWL 440
Peptidase_M1 pfam01433
Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ ...
400-616 8.93e-17

Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ widely in specificity, hydrolysing acidic, basic or neutral N-terminal residues. This family includes leukotriene-A4 hydrolase, this enzyme also has an aminopeptidase activity.


Pssm-ID: 426262 [Multi-domain]  Cd Length: 219  Bit Score: 80.03  E-value: 8.93e-17
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480  400 PFPRLDVLIVPSgFSSLGMASPHIVFLSQSVLTGERNLCGAR--------LCHEIAHSWFGLAIGARDWTEEWISEGFAT 471
Cdd:pfam01433  22 PLPKYDLVALPD-FSAGAMENWGLITYRETLLLYDPGNSSTSdkqrvasvIAHELAHQWFGNLVTMKWWDDLWLNEGFAT 100
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480  472 YLEDVFWSHVQklGCREAEEQRQLKALlrWRRLSDELQNSEEELQVlrpnkeNTGEVSEsgasvvkhalnPEKPFMQVHY 551
Cdd:pfam01433 101 YMEYLGTDALF--PEWNIWEQFLLDEV--QNAMARDALDSSHPITQ------NVNDPSE-----------IDDIFDAIPY 159
                         170       180       190       200       210       220
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 181344480  552 LKGYFLLKFLADQIGEEKFLQFFKVFVGKFHGQLILSQDFLQMLLDAfpamsSQGIALETIFSDW 616
Cdd:pfam01433 160 EKGASVLRMLETLLGEEVFQKGLRSYLKKFQYGNATTEDLWDALSEA-----SGPLDVDSFMDTW 219
M1_APN-Q_like cd09601
Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), ...
244-618 5.98e-12

Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), aminopeptidase Q (APQ), tricorn interacting factor F3, and endoplasmic reticulum aminopeptidase 1 (ERAP1); This M1 peptidase family includes eukaryotic and bacterial members: the catalytic domains of aminopeptidase N (APN), aminopeptidase Q (APQ, laeverin), endoplasmic reticulum aminopeptidase 1 (ERAP1) as well as tricorn interacting factor F3. Aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease, preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is considered a marker of differentiation since it is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. ERAP1, also known as endoplasmic reticulum aminopeptidase associated with antigen processing (ERAAP), adipocyte derived leucine aminopeptidase (A-LAP), or aminopeptidase regulating tumor necrosis factor receptor I (THFRI) shedding (ARTS-1), associates with the closely related ER aminopeptidase ERAP2, for the final trimming of peptides within the ER for presentation by MHC class I molecules. ERAP1 is associated with ankylosing spondylitis (AS), an inflammatory arthritis that predominantly affects the spine. ERAP1 also aids in the shedding of membrane-bound cytokine receptors. The tricorn interacting factor F3, together with factors F1 and F2, degrades the tricorn protease products, producing free amino acids, thus completing the proteasomal degradation pathway. F3 is homologous to F2, but not F1, and shows a strong preference for glutamate in the P1' position. APQ, also known as laeverin, is specifically expressed in human embryo-derived extravillous trophoblasts (EVTs) that invade the uterus during early placentation. It cleaves the N-terminal amino acid of various peptides such as angiotensin III, endokinin C, and kisspeptin-10, all expressed in the placenta in large quantities. APN is a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs are also putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341064 [Multi-domain]  Cd Length: 442  Bit Score: 68.38  E-value: 5.98e-12
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 244 PINNRALFPCQ-EPpvAM-STWQACVRAPCDFTVLmSGENQAFPEPAETGFQQWDYYVTMPMPASTFTIAVGQWleaevk 321
Cdd:cd09601  122 PTDARRAFPCFdEP--AFkATFDITITHPKGYTAL-SNMPPVESTELEDGWKTTTFETTPPMSTYLVAFVVGDF------ 192
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 322 vtnyvddklslpldsgdeEYIcshmdypcrfmvgPARVQTVIPHRVFAPSCHLQKAQdMVLPLLPLCLTAAHSVLGVH-P 400
Cdd:cd09601  193 ------------------EYI-------------ESTTKSGVPVRVYARPGKIEQGD-FALEVAPKILDFYEDYFGIPyP 240
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 401 FPRLDVLIVPSgFSSLGMASP-HIVFLSQSVLTGERNLCGARL-------CHEIAHSWFG-LaIGARDWTEEWISEGFAT 471
Cdd:cd09601  241 LPKLDLVAIPD-FAAGAMENWgLITYRETALLYDPKTSSASDKqrvaeviAHELAHQWFGnL-VTMKWWDDLWLNEGFAT 318
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 472 YLEDVFWSHVQ-KLGCREAEEQRQLKALLRwrrlSDELQNSeeelQVLRPNKENTGEVSESGASVVkhalnpekpfmqvh 550
Cdd:cd09601  319 YMEYLAVDKLFpEWNMWDQFVVDELQSALE----LDSLASS----HPIEVPVESPSEISEIFDAIS-------------- 376
                        330       340       350       360       370       380
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 181344480 551 YLKGYFLLKFLADQIGEEKFLQFFKVFVGKFHGQLILSQDFLQMLLDAfpAMSSQGIALETIFSDWLD 618
Cdd:cd09601  377 YSKGASVLRMLENFLGEEVFRKGLRKYLKKHAYGNATTDDLWEALQEA--SGESKPLDVKEIMDSWTL 442
M1_APN cd09602
Peptidase M1 family including aminopeptidase N catalytic domain; This model represents the ...
227-473 7.70e-07

Peptidase M1 family including aminopeptidase N catalytic domain; This model represents the catalytic domain of bacterial and eukaryotic aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341065 [Multi-domain]  Cd Length: 440  Bit Score: 52.13  E-value: 7.70e-07
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 227 RWTKDQDGRCCVYTMGSPINNRALFPCQEPPVAMSTWQACVRAPCDFTVLMSGEnqafPEPAET--GFQQWDYYVTMPMP 304
Cdd:cd09602  107 RFVDPADGETYLYTLFEPDDARRVFPCFDQPDLKATFTLTVTAPADWTVISNGP----ETSTEEagGRKRWRFAETPPLS 182
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 305 ASTFTIAVGQWleaeVKVTnyvddklslpldsgdeeyiCSHMDYPCRFMvgpARvQTVIPHRVFAPSCHLQKAQdmvlpl 384
Cdd:cd09602  183 TYLFAFVAGPY----HRVE-------------------DEHDGIPLGLY---CR-ESLAEYERDADEIFEVTKQ------ 229
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 181344480 385 lplCLTAAHSVLGV-HPFPRLDVLIVPsGFSSLGMASPHIVFLS-QSVLTGE--RNLCGAR---LCHEIAHSWFGLAIGA 457
Cdd:cd09602  230 ---GLDFYEDYFGIpYPFGKYDQVFVP-EFNFGAMENPGAVTFReSYLFREEptRAQRLRRantILHEMAHMWFGDLVTM 305
                        250
                 ....*....|....*.
gi 181344480 458 RDWTEEWISEGFATYL 473
Cdd:cd09602  306 KWWDDLWLNESFADFM 321
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH